U.S. President Donald Trump will reportedly pledge on immensely diminishing the human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) epidemic while scientists are still looking for the ultimate cure. The matter is expected to be part of Trump’s State of the Union address this week.
While an overall cure for HIV/AIDS has yet to be developed, Trump is eyeing to address the epidemic by reducing cases of its transmission with a 10-year program through 2030, various sources told POLITICO. To do this, the Trump administration is reportedly planning to initially focus on areas identified with the highest rates of HIV/AIDS diagnosed patients.
It was reported, however, that Trump’s State of the Union address speech was not yet finalized as of Sunday. But officials of the Department of Health and Human Services (HHS) purportedly encouraged the White House to make the HIV/AIDS epidemic one of the issues to be prioritized in the address. Trump’s reported 10-year program to fight HIV/AIDS shares the same time frame with the UNAIDS aiming to end the epidemic by 2030.
The Centers for Disease Control and Prevention (CDC) reports that around 1.1 million people living in the United States have been infected with HIV based on their latest available data in 2015. “The South has the highest number of people living with HIV, but if population size is taken into account, the Northeast has the highest rate of people living with HIV,” CDC adds. It was also reported that, in 2016 and 2017, the District of Columbia, Florida, Georgia, Louisiana, Maryland, and Nevada are some of the states with the highest rates of HIV diagnoses.
Trump’s State of the Union address supposedly took place last Tuesday but had to be delayed due to the latest government shutdown. The political event, expected to highlight the need to end HIV/AIDS, is now scheduled for Tuesday, Feb. 5, at 9 p.m. ET.


Lab-grown meat: you may find it icky, but it could drive forward medical research
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
U.S. Expected to Expand Travel Ban to More Than 30 Countries
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict
Tabletop particle accelerator could transform medicine and materials science
Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain
Pentagon Probe Finds Hegseth’s Use of Signal Risked Exposing Sensitive Yemen Strike Details
U.S. Justice Department Orders Intensified Probe Into Antifa and Domestic Extremist Groups 



